|
G |
Msmo1 |
methylsterol monoxygenase 1 |
decreases abundance |
ISO |
MSMO1 protein results in decreased abundance of 4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol |
CTD |
PMID:23125191 |
|
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
|
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases abundance |
ISO |
CYP51A1 mRNA results in decreased abundance of lanostenol |
CTD |
PMID:23125191 |
|
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
decreases activity |
ISO |
lanostenol results in decreased activity of HMGCR protein |
CTD |
PMID:18024962 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases metabolic processing |
ISO |
CYP27A1 protein results in increased metabolism of Lanosterol |
CTD |
PMID:14622972 |
|
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
multiple interactions |
ISO |
[Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Itraconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Ketoconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Voriconazole results in decreased metabolism of and results in increased abundance of Lanosterol] |
CTD |
PMID:12617470 PMID:18694951 |
|
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
multiple interactions |
EXP |
Lanosterol analog inhibits the reaction [EPHX1 protein results in increased metabolism of cholesterol alpha-oxide] |
CTD |
PMID:2043152 |
|
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
multiple interactions |
EXP |
Lanosterol analog inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] |
CTD |
PMID:2043152 |
|
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
|
|
G |
Marchf6 |
membrane associated ring-CH-type finger 6 |
increases stability |
ISO |
Lanosterol results in increased stability of MARCHF6 protein |
CTD |
PMID:30545937 |
|
NCBI chr15:31,456,045...31,531,172
Ensembl chr15:31,456,037...31,531,199
|
|
G |
Nr1h5 |
nuclear receptor subfamily 1, group H, member 5 |
increases activity |
EXP |
Lanosterol results in increased activity of NR1H5 protein |
CTD |
PMID:17567710 |
|
NCBI chr 3:102,846,974...102,871,607
Ensembl chr 3:102,846,974...102,871,449
|
|